Neurological Effect and Clinical Manifestations of COVID-19 in Elderly Population

Ranita Rusydina Daroh, Dede Renovaldi

Abstract


Background: Currently there is a new world health crisis which is urgent due to the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus. The elderly can be presented as a group of patients at high risk for developing covid-19 with progressive and rapid clinical deterioration including neurological manifestations. Many reports have emerged showing that SARS-CoV-2 infection has an impact on neurological function, and even causes serious neurological damage. Purposes: to investigate the possible correlation between aging process to the severity of neurological deterioration experienced in COVID-19 infection specifically by elderly people. Methods: literature searching was conducted through PubMed, MedLine and Embase. Results: Regardless of age, the infection of SARS-CoV-2 to both central and peripheral nervous system could lead into a range of neurological deteriorations, in which also ranging in forms and severity. Conclusion: In elderly patients, despite of comorbidities, the natural degeneration process is likely being a risk factor of more severe neurological symptoms of Covid-19 infection.

Keywords


Covid-19; Sars-CoV-2; Neurological Manifestations; Elderly

Full Text:

PDF

References


Garnier-Crussard A, Forestier E, Gilbert T, Krolak-Salmon P. Novel Coronavirus (COVID-19) Epidemic: What Are the Risks for Older Patients? Vol. 68, Journal of the American Geriatrics Society. 2020. p. 939–40.

Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect. 2020 Jun;80(6):e14–8.

Peters R. Ageing and the brain. Postgrad Med J. 2006 Feb;82(964):84–8.

Erickson M, Banks W. Age-Associated Changes in the Immune System and Blood–Brain Barrier Functions. Int J Mol Sci [Internet]. 2019 Apr 2;20(7):1632. Available from: https://www.mdpi.com/1422-0067/20/7/1632

Perrotta F, Corbi G, Mazzeo G, Boccia M, Aronne L, D’Agnano V, et al. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res. 2020 Aug;32(8):1599–608.

Ferini-Strambi L, Salsone M. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? J Neurol [Internet]. 2020 Jul 21;1–11. Available from: https://pubmed.ncbi.nlm.nih.gov/32696341

Trollor JN, Valenzuela MJ. Brain ageing in the new millennium. Aust N Z J Psychiatry. 2001 Dec;35(6):788–805.

Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg [Internet]. 2020 Jul;194:105921. Available from: https://linkinghub.elsevier.com/retrieve/pii/S030384672030264X

Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. 2020 May;13(5):667–73.

Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Gallagher T, editor. J Virol [Internet]. 2020 Mar 17;94(7):1–9. Available from: http://jvi.asm.org/content/94/7/e00127-20.abstract

Oh S-J, Lee JK, Shin OS. Aging and the Immune System: the Impact of Immunosenescence on Viral Infection, Immunity and Vaccine Immunogenicity. Immune Netw [Internet]. 2019 Nov 14;19(6):e37–e37. Available from: https://pubmed.ncbi.nlm.nih.gov/31921467

Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020 May;26(5):681–7.

Fosbøl EL, Butt JH, Østergaard L, Andersson C, Selmer C, Kragholm K, et al. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality. JAMA. 2020 Jul;324(2):168–77.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Vol. 8, The Lancet. Respiratory medicine. 2020. p. 420–2.

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost [Internet]. 2020/03/13. 2020 Apr;18(4):844–7. Available from: https://pubmed.ncbi.nlm.nih.gov/32073213

Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res [Internet]. 2020/04/10. 2020 Jul;191:145–7. Available from: https://pubmed.ncbi.nlm.nih.gov/32291094

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020 Feb;395(10223):497–506.

Dent E, Martin FC, Bergman H, Woo J, Romero-Ortuno R, Walston JD. Management of frailty: opportunities, challenges, and future directions. Lancet (London, England). 2019 Oct;394(10206):1376–86.

Dhama K, Patel SK, Kumar R, Rana J, Yatoo MI, Kumar A, et al. Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond. Front public Heal [Internet]. 2020 Sep 22;8:574198. Available from: https://pubmed.ncbi.nlm.nih.gov/33072713

Daroedono E, Siagian FE, Alfarabi M, Cing JM, Arodes ES, Sirait RH, et al. The impact of COVID-19 on medical education: our students perception on the practice of long distance learning. Int J Community Med Public Heal. 2020;7(7):2790.

Khatoon F, Prasad K, Kumar V. Neurological manifestations of COVID-19: available evidences and a new paradigm. J Neurovirol [Internet]. 2020;26(5):619–30. Available from: https://doi.org/10.1007/s13365-020-00895-4

Abboud H, Abboud FZ, Kharbouch H, Arkha Y, El Abbadi N, El Ouahabi A. COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurg [Internet]. 2020/05/28. 2020 Aug;140:49–53. Available from: https://pubmed.ncbi.nlm.nih.gov/32474093

Wong PF, Craik S, Newman P, Makan A, Srinivasan K, Crawford E, et al. Lessons of the month 1: A case of rhombencephalitis as a rare complication of acute COVID-19 infection. Clin Med. 2020 May;20(3):293–4.

Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Vol. 94, International journal of infectious diseases. 2020. p. 55–8.

Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol. 2020 Sep;19(9):767–83.

Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS, et al. Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients. Ann Clin Transl Neurol [Internet]. 2020 Nov 5;7(11):2221–30. Available from: https://onlinelibrary.wiley.com/doi/10.1002/acn3.51210

Rahman A, Niloofa R, De Zoysa IM, Cooray AD, Kariyawasam J, Seneviratne SL. Neurological manifestations in COVID-19: A narrative review. SAGE Open Med [Internet]. 2020 Jan 10;8. Available from: http://journals.sagepub.com/doi/10.1177/2050312120957925

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020 Aug;296(2):E119–20.

Bianchetti A, Rozzini R, Guerini F, Boffelli S, Ranieri P, Minelli G, et al. Clinical Presentation of COVID19 in Dementia Patients. J Nutr Health Aging [Internet]. 2020;24(6):560–2. Available from: https://pubmed.ncbi.nlm.nih.gov/32510106




DOI: https://doi.org/10.24853/mujg.1.2.58-67

Refbacks

  • There are currently no refbacks.


Indexed by:

     

 

Lisensi Creative Commons

Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial 4.0 Internasional.

Copyright of Muhammadiyah Journal of Geriatric (e issn: 2721-6837)

Powered by Puskom-UMJ